This ligand improved blood–brain barrier permeability, targeting glioma cells, and [Asn6, Pro34]-NPY nano micelles also improved the therapeutic effect of doxorubicin against these cells, leading to a high survival rate [86]. The gene discussed is NPY; the disease is central nervous system cancer.